Indication
Paget's disease of bone
Paget's disease of bone is a chronic skeletal disorder marked by focal dysregulation of the bone remodeling cycle. Read more about Paget's disease of bone
44 drugs 31 manufacturers
Drugs that treat it
Common Paget's disease of bone therapies.
ZOLEDRONIC ACID (zoledronic acid in mannitol and water for injection)
ZOLEDRONIC ACID (zoledronic acid in mannitol and water for injection)
ZOLEDRONIC ACID (zoledronic acid in mannitol and water for injection)
ACTONEL (risedronate sodium)
ZOLEDRONIC ACID (zoledronic acid in mannitol and water for injection)
PAMIDRONATE DISODIUM
PAMIDRONATE DISODIUM
ACTONEL (risedronate sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPaget's disease of bone is a chronic skeletal disorder marked by focal dysregulation of the bone remodeling cycle.
It predominantly affects adults over the age of 50 and involves one or more localized skeletal sites, most commonly the pelvis, spine, femur, and skull.
Pathophysiologically, hyperactive osteoclasts drive excessive bone resorption followed by disorganized osteoblastic new bone formation, producing an irregular mosaic of weakened, structurally compromised, and highly vascularized bone.
While often asymptomatic, affected individuals may develop deep bone pain, skeletal deformities, secondary osteoarthritis, fractures, and neurological compressions such as hearing loss.
- nih.gov
Paget's disease of bone is a chronic skeletal disorder marked by focal dysregulation of the bone remodeling cycle Pathophysiologically, hyperactive osteoclasts drive excessive bone resorption followed by disorganized osteoblastic new bone formation, producing an irregular mosaic of weakened, structurally compromised, and highly vascularized bone While often asymptomatic, affected individuals may develop deep bone pain, skeletal deformities, secondary osteoarthritis, fractures, and neurological c...
- youtube.com
Paget's disease of bone is a chronic skeletal disorder marked by focal dysregulation of the bone remodeling cycle
- medlineplus.gov
It predominantly affects adults over the age of 50 and involves one or more localized skeletal sites, most commonly the pelvis, spine, femur, and skull
- mayoclinic.org
It predominantly affects adults over the age of 50 and involves one or more localized skeletal sites, most commonly the pelvis, spine, femur, and skull While often asymptomatic, affected individuals may develop deep bone pain, skeletal deformities, secondary osteoarthritis, fractures, and neurological compressions such as hearing loss
- lluh.org
It predominantly affects adults over the age of 50 and involves one or more localized skeletal sites, most commonly the pelvis, spine, femur, and skull
- nih.gov
Pathophysiologically, hyperactive osteoclasts drive excessive bone resorption followed by disorganized osteoblastic new bone formation, producing an irregular mosaic of weakened, structurally compromised, and highly vascularized bone
- nih.gov
While often asymptomatic, affected individuals may develop deep bone pain, skeletal deformities, secondary osteoarthritis, fractures, and neurological compressions such as hearing loss
Personalize your experience
Follow Paget's disease of bone and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.